Summary:
- The article discusses a clinical trial for a new HIV vaccine being conducted by USAID (the United States Agency for International Development).
- The trial is taking place in four countries in sub-Saharan Africa and aims to enroll 5,400 participants to test the safety and efficacy of the vaccine.
- If successful, the vaccine could potentially help control the HIV/AIDS epidemic, which continues to be a major global health challenge, particularly in parts of Africa.